Skip to main content

Table 2 Targeting posttranslational modification of cancer lipid metabolism enzymes for cancer treatment

From: Posttranslational control of lipogenesis in the tumor microenvironment

Protein

Targeting PTMs

Drugs

Function

References

HMGCR

De-ubiquitination

GSK2643943A

To de-stabilize HMGCR

[133]

FXR

SUMOylation

SP/GA

To enhance FXR protein levels

[190,191,192]

ME1

Phosphorylation

Ulixertinib

To repress ME1 de-ubiquitination and promote it degradation

[193]

GNPAT

Acetylation

AH

Mediated GNPAT ubiquitination and degradation

[139]

SREBP1

Phosphorylation

Sorafenib

Reduction SREBP1 protein levels

[194]

SREBP1

Phosphorylation

Silibinin

To block SREBP1 nuclear translocation

[195]